Deliberate organization of patient care activities and information sharing among all of the participants, such as clinicians, caregivers, and/or social workers, concerned with a patient's care to achieve safer and more effective care.²

Medications for opioid use disorder (MOUD)

Three Food and Drug Administration (FDA) approved medications to treat opioid use disorder (OUD): methadone, naltrexone, and buprenorphine.³

Opioid use disorder (OUD)

A problematic pattern of opioid use leading to clinically significant impairment or distress. A diagnosis is based on specific Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria, such as unsuccessful efforts to cut down or control use, or use resulting in social problems and a failure to fulfill obligations at work, school, or home, among other criteria.⁴

Opioid treatment program (OTP)

An accredited treatment program with Substance Abuse and Mental Health Services (SAMHSA) certification and Drug Enforcement Administration (DEA) registration to administer and dispense opioid agonist medications that are approved by the Food and Drug Administration (FDA) to treat opioid addiction.³

Substance Abuse and Mental Health Services Administration (SAMHSA). (2022, March). Buprenorphine. Retrieved from https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions/buprenorphine
Agency for Healthcare Research and Quality. (2018, August). Care Coordination. Retrieved September 6, 2022, from https://www.ahrq.gov/ncepcr/care/coordination.html
Treatment Improvement Protocol (TIP) Series 63: Medications for Opioid Use Disorder. (2021). Substance Abuse and Mental Health Services Administration. Publication No. PEP21-02-01-002. Retrieved September 6, 2022, from https://store.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/PEP21-02-01-002.pdf
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association, 2013.